Dr. Matsui's research integrates cancer, developmental, and stem cell biology. His laboratory originally characterized stem cells in the plasma cell malignancy multiple myeloma then expanded their studies to include solid tumors and malignant hematopoiesis. His research is focused on defining the determinants of self-renewal in cancer and the development of novel therapeutic strategies. Dr. Matsui's research is notable for its consistently translational approach, and his preclinical findings have served as the scientific basis for over a dozen clinical trials. Dr. Matsui's research has been supported by the NIH and the National Cancer Institute, The International Myeloma Foundation, The Sidney Kimmel Foundation for Cancer Research, The Gabrielle's Angel Foundation, The Lustgarten Foundation, The Multiple Myeloma Research Foundation, and the Leukemia and Lymphoma Society.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811